IRIS Accounts Production v24.3.2.46 04682225 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh046822252023-04-30046822252024-04-30046822252023-05-012024-04-30046822252022-04-30046822252022-05-012023-04-30046822252023-04-3004682225ns15:EnglandWales2023-05-012024-04-3004682225ns14:PoundSterling2023-05-012024-04-3004682225ns10:Director12023-05-012024-04-3004682225ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3004682225ns10:SmallEntities2023-05-012024-04-3004682225ns10:AuditExemptWithAccountantsReport2023-05-012024-04-3004682225ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3004682225ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3004682225ns10:FullAccounts2023-05-012024-04-300468222512023-05-012024-04-3004682225ns10:Director22023-05-012024-04-3004682225ns10:RegisteredOffice2023-05-012024-04-3004682225ns5:CurrentFinancialInstruments2024-04-3004682225ns5:CurrentFinancialInstruments2023-04-3004682225ns5:Non-currentFinancialInstruments2024-04-3004682225ns5:Non-currentFinancialInstruments2023-04-3004682225ns5:ShareCapital2024-04-3004682225ns5:ShareCapital2023-04-3004682225ns5:CapitalRedemptionReserve2024-04-3004682225ns5:CapitalRedemptionReserve2023-04-3004682225ns5:RetainedEarningsAccumulatedLosses2024-04-3004682225ns5:RetainedEarningsAccumulatedLosses2023-04-3004682225ns5:NetGoodwill2023-05-012024-04-3004682225ns5:LeaseholdImprovements2023-05-012024-04-3004682225ns5:PlantMachinery2023-05-012024-04-3004682225ns5:FurnitureFittings2023-05-012024-04-3004682225ns5:MotorVehicles2023-05-012024-04-3004682225ns5:ComputerEquipment2023-05-012024-04-3004682225ns5:NetGoodwill2023-04-3004682225ns5:NetGoodwill2024-04-3004682225ns5:NetGoodwill2023-04-3004682225ns5:LeaseholdImprovements2023-04-3004682225ns5:PlantMachinery2023-04-3004682225ns5:FurnitureFittings2023-04-3004682225ns5:LeaseholdImprovements2024-04-3004682225ns5:PlantMachinery2024-04-3004682225ns5:FurnitureFittings2024-04-3004682225ns5:LeaseholdImprovements2023-04-3004682225ns5:PlantMachinery2023-04-3004682225ns5:FurnitureFittings2023-04-3004682225ns5:MotorVehicles2023-04-3004682225ns5:ComputerEquipment2023-04-3004682225ns5:MotorVehicles2024-04-3004682225ns5:ComputerEquipment2024-04-3004682225ns5:MotorVehicles2023-04-3004682225ns5:ComputerEquipment2023-04-3004682225ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3004682225ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 04682225 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024

FOR

CAIN BIO-ENGINEERING LIMITED

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Accountants' Report 9

CAIN BIO-ENGINEERING LIMITED

COMPANY INFORMATION
for the year ended 30 April 2024







DIRECTORS: Mr S Cain
Mr W J Stringer



REGISTERED OFFICE: The Old Dairy Station Approach
Woodgreen Road
Breamore
Fordingbridge
Hampshire
SP6 2AB



REGISTERED NUMBER: 04682225 (England and Wales)



ACCOUNTANTS: Rothmans LLP
10 St Ann Street
Salisbury
Wiltshire
SP1 2DN



BANKERS: HSBC Plc
19 Minster Street
Salisbury
Wiltshire
SP1 1TE

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

BALANCE SHEET
30 April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 170,639 114,238
170,639 114,238

CURRENT ASSETS
Stocks 4,185 7,096
Debtors 6 242,773 220,124
Cash at bank 292,007 218,610
538,965 445,830
CREDITORS
Amounts falling due within one year 7 357,319 272,897
NET CURRENT ASSETS 181,646 172,933
TOTAL ASSETS LESS CURRENT
LIABILITIES

352,285

287,171

CREDITORS
Amounts falling due after more than one
year

8

(10,951

)

(20,921

)

PROVISIONS FOR LIABILITIES (22,365 ) (12,380 )
NET ASSETS 318,969 253,870

CAPITAL AND RESERVES
Called up share capital 99 99
Capital redemption reserve 9 1 1
Retained earnings 9 318,869 253,770
SHAREHOLDERS' FUNDS 318,969 253,870

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

BALANCE SHEET - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 January 2025 and were signed on its behalf by:





Mr S Cain - Director


CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 30 April 2024

1. STATUTORY INFORMATION

Cain Bio-Engineering Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Revenue recognition
Revenue is measured at the fair value of the consideration received or receivable for the provision of river restoration and erosion control projects.

Revenue is recognised once the services provided have been approved or agreed by the client, at which time the significant risks and rewards of ownership of the work undertaken have transferred to the client.

Profit is recognised on long term projects when the final outcome can be assessed with reasonable certainty by including turnover and related costs within the profit and loss account dependent upon the stage of completion at the balance sheet date.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

The assets' residual values, useful lives and amortisation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting period.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on cost
Computer equipment - 33% on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting period.

Stocks
The company holds stocks of materials and consumables. As these stocks are not subject to physical obsolescence they are valued at cost. Materials are purchased as required on a project by project basis.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 April 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Debtors do not carry any interest and are stated at their nominal value. Appropriate allowances for estimated irrecoverable amounts are recognised in the Profit and Loss account when there is objective evidence that the asset is impaired.

Creditors
Creditors are not interest bearing and are stated at their nominal value.

Cash and cash equivalents
These comprise cash at bank and other short term highly liquid deposits.

Reserves
The movement in the fair value of motor vehicles to open market value at the balance sheet date is recognised in a non-distributable reserve. This reserve, which also contains appropriate deferred tax provisions, may not be distributed to the shareholders.

Any movements in the reserve are not liable to corporation tax and an appropriate deferred tax provision is provided within the reserve.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 16 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2023
and 30 April 2024 70,000
AMORTISATION
At 1 May 2023
and 30 April 2024 70,000
NET BOOK VALUE
At 30 April 2024 -
At 30 April 2023 -

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 April 2024

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   
COST OR VALUATION
At 1 May 2023 249,845 197,536 2,277
Additions 15,105 15,105 5,135
Disposals - (6,500 ) -
Revaluations - 56,298 -
At 30 April 2024 264,950 262,439 7,412
DEPRECIATION
At 1 May 2023 186,355 170,000 868
Charge for year 18,163 11,900 833
Eliminated on disposal - (6,294 ) -
At 30 April 2024 204,518 175,606 1,701
NET BOOK VALUE
At 30 April 2024 60,432 86,833 5,711
At 30 April 2023 63,490 27,536 1,409

Motor Computer
vehicles equipment Totals
£    £    £   
COST OR VALUATION
At 1 May 2023 61,544 22,004 533,206
Additions 4,500 1,240 41,085
Disposals (26,294 ) - (32,794 )
Revaluations - - 56,298
At 30 April 2024 39,750 23,244 597,795
DEPRECIATION
At 1 May 2023 41,113 20,632 418,968
Charge for year 7,287 993 39,176
Eliminated on disposal (24,694 ) - (30,988 )
At 30 April 2024 23,706 21,625 427,156
NET BOOK VALUE
At 30 April 2024 16,044 1,619 170,639
At 30 April 2023 20,431 1,372 114,238

Cost or valuation at 30 April 2024 is represented by:

Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   

Valuation in 2024 - 56,298 -
Cost 264,950 206,141 7,412
264,950 262,439 7,412

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 April 2024

5. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
Valuation in 2020 10,000 - 10,000
Valuation in 2024 - - 56,298
Cost 29,750 23,244 531,497
39,750 23,244 597,795

If motor vehicles and plant had not been revalued they would have been included at the following historical cost:

30.4.24 30.4.23
£    £   
Cost 235,891 249,080
Aggregate depreciation 220,299 201,513

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 184,665 149,675
Other debtors 58,108 70,449
242,773 220,124

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 10,648 10,648
Trade creditors 89,289 107,379
Taxation and social security 62,566 88,016
Other creditors 194,816 66,854
357,319 272,897

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans 10,951 20,921

CAIN BIO-ENGINEERING LIMITED (REGISTERED NUMBER: 04682225)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 April 2024

9. RESERVES

30.4.24 30.4.23
£ £

Distributable274,636253,770
Non - distributable44,233-
318,869253,770


Movement in Non-distributable reserve 30.4.2430.4.23
£ £

Balance brought forward at the start of the year-2,025
Fair value uplift56,298-
Movement in depreciation-(2,500)
Movement in deferred tax(12,065)475
Balance carried forward at the end of the year44,233-




10. RELATED PARTY DISCLOSURES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:
30.4.24 30.4.23
£ £

Balance outstanding at the start of the year - -
Amounts advanced 19,765 28,037
Amount repaid (19,765 ) (28,037 )
Balance outstanding at the end of the year - -
Interest was charged on the loans at commercial rates and the loans are repayable on demand.









ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
CAIN BIO-ENGINEERING LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Statement of Comprehensive Income and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Cain Bio-Engineering Limited for the year ended 30 April 2024 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Cain Bio-Engineering Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Cain Bio-Engineering Limited and state those matters that we have agreed to state to the Board of Directors of Cain Bio-Engineering Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Cain Bio-Engineering Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Cain Bio-Engineering Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Cain Bio-Engineering Limited. You consider that Cain Bio-Engineering Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Cain Bio-Engineering Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Rothmans LLP
10 St Ann Street
Salisbury
Wiltshire
SP1 2DN


21 January 2025